Brookdale Senior Living $125 million tangible equity units offering
The offering comprised 2.5 million units
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Privia Health $135 million secondary offering
We advised Privia on its debut shelf takedown offering
Tenaya Therapeutics $75 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Natera $400 million follow-on offering
The shares are listed on Nasdaq
Zoetis $1.35 billion senior notes offering
The investment-grade notes are due 2025 and 2032
Roivant Sciences $150 million equity offering
We advised the company on its debut SEC-registered primary and secondary offering
Akoya Biosciences $50 million at-the-market program
The common stock is listed on the Nasdaq Global Select Market
Elevance Health $1.8 billion senior notes offering
The investment-grade notes are due 2025, 2032 and 2052
NextGen Healthcare $275 million convertible senior notes offering
The 3.75% convertible notes are due 2027
Recursion Pharmaceuticals $150 million private placement
We advised the placement agents on the private placement of common stock